Use of next-generation sequencing (NGS) to study the impact of demographic variables on prevalence of driver mutations in non-small cell lung cancer (NSCLC).

被引：0

作者：

Choi, WonSeok William

Haroun, Faysal

机构：

[1] George Washington Univ, Sch Med & Hlth Sci, Washington, DC USA

[2] George Washington Univ, Washington, DC USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e21030

引用

页数：1

共 50 条

[1] Concordance of driver mutations in primary and matched metastasis from patients with non-small cell lung cancer (NSCLC) using next-generation sequencing (NGS).
Vignot, Stephane
Frampton, Garrett
Yelensky, Roman
Brambilla, Christian
Toffart, Anne-Claire
Miller, Vincent A.
Palmer, Gary A.
Cronin, Maureen T.
Lazar, Vladimir
Soria, Jean-Charles
Stephens, Philip
Brambilla, Elisabeth
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[2] A Pathology Group Experience with Targeted Next-Generation Sequencing (NGS) for Non-Small Cell Lung Cancer (NSCLC)
Xu, D.
Zhang, M.
Keenan, S. O.
Coleman, R.
Tevis, A. Larson
Rushford, C.
Christensen, T.
[J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1226 - 1226
[3] Molecular Characterization by Next-Generation Sequencing (NGS) of Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Immunotherapy
Cruz Castellanos, P.
Rosas Alonso, R.
Ozaez, I.
Hernandez, I.
Losantos, I.
Gutierrez Sainz, L.
Higuera Gomez, O.
Rodriguez Antolin, C.
Esteban Rodriguez, I.
Ibanez de Caceres, I.
de Castro Carpeno, J.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S558 - S558
[4] Detection of driver mutation heterogeneity in patients with non-small cell lung cancer (NSCLC) using next generation sequencing (NGS)
Chilingirova, N.
Balabanski, L.
Kurteva, G.
Toncheva, D.
Damyanov, D.
Chilingirov, P.
[J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S612 - S613
[5] Clinical impact of plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC)
Bonanno, L.
Pavan, A.
Ferro, A.
Calvetti, L.
Frega, S.
Pasello, G.
Aprile, G.
Guarneri, V.
Conte, P. F.
[J]. ANNALS OF ONCOLOGY, 2019, 30 : 577 - 577
[6] Feasibility of next-generation sequencing (NGS) for squamous non-small cell lung cancer (NSCLC): Implications for the NCI LungMAP study.
Sacher, Adrian G.
Sholl, Lynette M.
Mach, Stacy L.
Johnson, Bruce E.
Hammerman, Peter S.
Janne, Pasi A.
Oxnard, Geoffrey R.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[7] TP53 fusions with next-generation sequencing (NGS) in Chinese non-small cell lung cancer (NSCLC): A multicenter study.
Chen, Huafei
Wang, Wen Xian
Xu, Chunwei
Zhu, You-cai
Zhuang, Wu
Huang, Yun-jian
Fang, Yong
Wang, Hong
Zhang, Yinbin
Wang, Yafei
Chen, Meifang
Li, Jinluan
Wang, Liping
Cai, Shangli
Fang, Meiyu
Chen, Gang
Lv, Tangfeng
Song, Yong
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[8] Next generation sequencing (NGS) in resectable non-small cell lung cancer (NSCLC): Therapeutic implications.
Rusch, Valerie W.
Tan, Kay See
Ghanie, Amanda
Arcila, Maria E.
Travis, William D.
Jones, David Randolph
Park, Bernard J.
Huang, James
Rudin, Charles M.
Hyman, David Michael
Solit, David B.
Berger, Michael F.
Baselga, Jose
Ladanyi, Marc
Riely, Gregory J.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[9] Diagnostic and Economic Value of Next-Generation Sequencing (NGS) in Genotyping Non-Small Cell Lung Cancer Tumors (NSCLC): A Literature Review
Zheng, Y.
Vioix, H.
Liu, F. X.
Singh, B.
Sharma, S.
Sharma, S.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S39 - S39
[10] Clinical and economic benefits of using next-generation sequencing (NGS) in the diagnostics of patients with non-small cell lung cancer with rare mutations
Stencel, Katarzyna
Wasag, Bartosz
Pruszko, Cezary
Dabrowska, Krystyna
Ksiazek, Pawel
Dziadek, Karolina
Bryl, Maciej
Krzakowski, Maciej
[J]. ONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (03): : 201 - 208

← 1 2 3 4 5 →